NCT06194617View on ClinicalTrials.gov

Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Pulmonary EmbolismVenous ThromboembolismAnticoagulant-induced Bleeding
Interventions
DRUG

Direct oral anticoagulant

Patients take DOACs according to their condition, with the dosage determined by the clinical physician.

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER